GB9509844D0 - Screening for inhibitors of TCR-MHC interactions - Google Patents

Screening for inhibitors of TCR-MHC interactions

Info

Publication number
GB9509844D0
GB9509844D0 GBGB9509844.8A GB9509844A GB9509844D0 GB 9509844 D0 GB9509844 D0 GB 9509844D0 GB 9509844 A GB9509844 A GB 9509844A GB 9509844 D0 GB9509844 D0 GB 9509844D0
Authority
GB
United Kingdom
Prior art keywords
tcr
inhibitors
screening
mhc interactions
mhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9509844.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Priority to GBGB9509844.8A priority Critical patent/GB9509844D0/en
Publication of GB9509844D0 publication Critical patent/GB9509844D0/en
Priority to AU57690/96A priority patent/AU5769096A/en
Priority to PCT/GB1996/001165 priority patent/WO1996036881A2/en
Pending legal-status Critical Current

Links

GBGB9509844.8A 1995-05-16 1995-05-16 Screening for inhibitors of TCR-MHC interactions Pending GB9509844D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9509844.8A GB9509844D0 (en) 1995-05-16 1995-05-16 Screening for inhibitors of TCR-MHC interactions
AU57690/96A AU5769096A (en) 1995-05-16 1996-05-16 Screening for inhibitors of tcr-mhc interactions
PCT/GB1996/001165 WO1996036881A2 (en) 1995-05-16 1996-05-16 Screening for inhibitors of tcr-mhc interactions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9509844.8A GB9509844D0 (en) 1995-05-16 1995-05-16 Screening for inhibitors of TCR-MHC interactions

Publications (1)

Publication Number Publication Date
GB9509844D0 true GB9509844D0 (en) 1995-07-12

Family

ID=10774510

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9509844.8A Pending GB9509844D0 (en) 1995-05-16 1995-05-16 Screening for inhibitors of TCR-MHC interactions

Country Status (3)

Country Link
AU (1) AU5769096A (en)
GB (1) GB9509844D0 (en)
WO (1) WO1996036881A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031625A1 (en) 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
US6309820B1 (en) 1995-04-07 2001-10-30 University Of North Carolina At Chapel Hill Polypeptides having a functional domain of interest and methods of identifying and using same
WO1997044667A2 (en) * 1996-05-21 1997-11-27 Institut Pasteur Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells
AU2481399A (en) * 1998-01-29 1999-08-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Variant peptide ligands that selectively induce apoptosis
WO2001090747A2 (en) * 2000-05-25 2001-11-29 Sunol Molecular Corporation Modulation of t-cell receptor interactions
US20210371849A1 (en) * 2018-07-31 2021-12-02 Janux Therapeutics, Inc. Inhibitory t cell receptor peptides and discovery methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU669329B2 (en) * 1991-03-22 1996-06-06 Trustees Of The University Of Pennsylvania, The Method of modulating mammalian T-cell response
CN1135181A (en) * 1993-09-14 1996-11-06 Cytel有限公司 Alteration of immune response using pan Dr-binding peptides

Also Published As

Publication number Publication date
WO1996036881A2 (en) 1996-11-21
WO1996036881A3 (en) 1997-01-09
AU5769096A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
PL327569A1 (en) Promedications of thrombosin inhibitors
IL122266A0 (en) Inhibitors of phospholipase A2
EP0794789A4 (en) Inhibitors of prenyl transferases
AU8256098A (en) Systems and methods for parallel synthesis of compounds
PL324527A1 (en) Cyclic inhibitors of gmp-specific phosphodisterase
EP0835109A4 (en) Pyridinone-thrombin inhibitors
PL321759A1 (en) Novel thrombosin inhibitors
IL118101A0 (en) Inhibitors of farnesyltransferase
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
EP0769065A4 (en) Methods for identifying inhibitors of integrin activation
HUP9900110A3 (en) Novel process for the synthesis of omeprazole
AU8245898A (en) Apparatus for sanitary packing of used objects
PL321659A1 (en) Bidged indoles as inhibitors of matrix metaloproteases
AU6692996A (en) Inhibitors of apoptosis
AU6904596A (en) Method and construct for screening for inhibitors of transcriptional activation
ZA9610798B (en) Inhibitors of interleuken-1beta converting enzyme
AU5512096A (en) Method of inhibiting restenosis using calreticulin
GB9509844D0 (en) Screening for inhibitors of TCR-MHC interactions
IL124871A0 (en) Naphthyl glyoxamides as spla2 inhibitors
GB9701245D0 (en) Method of screening compounds
GB9502985D0 (en) Enzyme inhibitors
IL113228A0 (en) Derivatives of anandamide
IL123507A (en) Set of structural elements for constructions
GB9421118D0 (en) Method of screening for CD31 interaction inhibitors
PL322822A1 (en) Method of obtaining streptogramins